BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9989937)

  • 21. Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.
    Xu B; Monsarrat B; Gairin JE; Girbal-Neuhauser E
    Fundam Clin Pharmacol; 2004 Apr; 18(2):171-80. PubMed ID: 15066131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells.
    Wójcik C; Schroeter D; Stoehr M; Wilk S; Paweletz N
    Eur J Cell Biol; 1996 Jun; 70(2):172-8. PubMed ID: 8793390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophoretic analysis of phosphorylation of the yeast 20S proteasome.
    Iwafune Y; Kawasaki H; Hirano H
    Electrophoresis; 2002 Jan; 23(2):329-38. PubMed ID: 11840541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proteasome activator 11 S REG or PA28: chimeras implicate carboxyl-terminal sequences in oligomerization and proteasome binding but not in the activation of specific proteasome catalytic subunits.
    Li J; Gao X; Joss L; Rechsteiner M
    J Mol Biol; 2000 Jun; 299(3):641-54. PubMed ID: 10835274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition.
    Schwarz K; Eggers M; Soza A; Koszinowski UH; Kloetzel PM; Groettrup M
    Eur J Immunol; 2000 Dec; 30(12):3672-9. PubMed ID: 11169410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural plasticity of the proteasome and its function in antigen processing.
    Groettrup M; van den Broek M; Schwarz K; Macagno A; Khan S; de Giuli R; Schmidtke G
    Crit Rev Immunol; 2001; 21(4):339-58. PubMed ID: 11922078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH.
    Figueiredo-Pereira ME; Chen WE; Yuan HM; Wilk S
    Arch Biochem Biophys; 1995 Feb; 317(1):69-78. PubMed ID: 7872805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific proteolytic cleavages limit the diversity of the pool of peptides available to MHC class I molecules in living cells.
    Serwold T; Shastri N
    J Immunol; 1999 Apr; 162(8):4712-9. PubMed ID: 10202012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta.
    Murata S; Udono H; Tanahashi N; Hamada N; Watanabe K; Adachi K; Yamano T; Yui K; Kobayashi N; Kasahara M; Tanaka K; Chiba T
    EMBO J; 2001 Nov; 20(21):5898-907. PubMed ID: 11689430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasome-cytochrome c interactions: a model system for investigation of proteasome host-guest interactions.
    Huffman HA; Sadeghi M; Seemuller E; Baumeister W; Dunn MF
    Biochemistry; 2003 Jul; 42(29):8679-86. PubMed ID: 12873127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues.
    Cardozo C; Michaud C; Orlowski M
    Biochemistry; 1999 Jul; 38(30):9768-77. PubMed ID: 10423257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
    J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolytic degradation of tyrosine nitrated proteins.
    Souza JM; Choi I; Chen Q; Weisse M; Daikhin E; Yudkoff M; Obin M; Ara J; Horwitz J; Ischiropoulos H
    Arch Biochem Biophys; 2000 Aug; 380(2):360-6. PubMed ID: 10933892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome.
    Wójcik C; Schroeter D; Wilk S; Lamprecht J; Paweletz N
    Eur J Cell Biol; 1996 Nov; 71(3):311-8. PubMed ID: 8929570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of Candida albicans 20S proteasome: identification of four proteasomal subunits.
    Fernández Murray P; Biscoglio MJ; Passeron S
    Arch Biochem Biophys; 2000 Mar; 375(2):211-9. PubMed ID: 10700377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxynitrite alters the catalytic activity of rodent liver proteasome in vitro and in vivo.
    Osna NA; Haorah J; Krutik VM; Donohue TM
    Hepatology; 2004 Sep; 40(3):574-82. PubMed ID: 15349895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic peptide-based activators of the proteasome.
    Wilk S; Chen WE
    Mol Biol Rep; 1997 Mar; 24(1-2):119-24. PubMed ID: 9228292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex.
    Orlowski M; Wilk S
    Arch Biochem Biophys; 2000 Nov; 383(1):1-16. PubMed ID: 11097171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The components of the proteasome system and their role in MHC class I antigen processing.
    Krüger E; Kuckelkorn U; Sijts A; Kloetzel PM
    Rev Physiol Biochem Pharmacol; 2003; 148():81-104. PubMed ID: 12687403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The proteasome activator 11 S REG (PA28) and class I antigen presentation.
    Rechsteiner M; Realini C; Ustrell V
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):1-15. PubMed ID: 10600633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.